Three-year Effectiveness and Safety of Vedolizumab for IBD Three-year Effectiveness and Safety of Vedolizumab for IBD

This study examined the effectiveness and safety of long-term vedolizumab maintenance therapy in patients with moderate-to-severe active ulcerative colitis and Crohn ' s disease.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news